Jennifer Phillips
Algemeen Adviseur bij PHIO PHARMACEUTICALS CORP.
Oorsprong van het eerstegraads netwerk van Jennifer Phillips
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 13 | |
Public Company | Biotechnology | 8 | |
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Dermik Laboratories, Inc.
Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Dermik Laboratories, Inc. manufactures health and skin care products. Its products and services include acne, actinic keratosis, nail fungus, dermatitis and eczema, and chemical peels treatment. The company was founded in 1947 and is located in Berwyn, PA.
4
| Operating Division | Household/Personal Care | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jennifer Phillips via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Undergraduate Degree | |
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director/Board Member | |
TELETOUCH COMMUNICATIONS, INC. | Specialty Telecommunications | Director/Board Member | |
BG MEDICINE, INC. | Medical Specialties | Corporate Officer/Principal | |
Elan Drug Delivery, Inc.
Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Drug Delivery, Inc. is engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use. The company is based in King Of Prussia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Pharmaceuticals: Major | Founder | |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Tikvah Therapeutics, Inc. acquires, develops and commercializes therapeutics addressing medical needs relating to the central nervous system. Its products include TIK-101 (dCS) and TIK-201(NaPB). The company was founded in April 2006 and is located in Atlanta, GA. | Medical Specialties | Director/Board Member | |
CORMEDIX INC. | Biotechnology | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
BTG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Isolagen Technologies, Inc.
Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director of Finance/CFO Chief Executive Officer Chief Executive Officer | |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Jones International University | College/University | Masters Business Admin | |
Sam Houston State University | College/University | Undergraduate Degree | |
Villanova University | College/University | Graduate Degree Undergraduate Degree | |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
Rosalind Franklin University of Medicine & Science | College/University | Graduate Degree | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
OPKO HEALTH, INC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
CHROMADEX CORPORATION | Pharmaceuticals: Other | Director/Board Member | |
WINSTON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Ruth K. Broad Biomedical Research Foundation, Inc. | Director/Board Member | ||
SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ELAN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Guardum Pharmaceuticals LLC
Guardum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Guardum Pharmaceuticals LLC produces pharmaceutical preparations. The company is based in Miami, FL. Guardum Pharmaceuticals was acquired by Pharmsynthez PJSC on April 18, 2013. | Pharmaceuticals: Major | Chief Executive Officer | |
Columbia Business School | College/University | Masters Business Admin | |
XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
SciVac Ltd.
SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Biotechnology | Chief Executive Officer | |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor | |
VBI VACCINES INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Orthogon Therapeutics LLC
Orthogon Therapeutics LLC Pharmaceuticals: MajorHealth Technology Orthogon Therapeutics LLC is a privately held R&D firm that specializes in drug discovery and development. The company is based in Canton, MA. The company is headquartered in the biotech hub of Greater Boston and has a branch in Leuven. Orthogon uses an innovative structure-based and biophysics platform to design novel medicines. The company's portfolio of infectious disease assets includes antiviral therapeutics, with a lead program being a first-in-class, orally administrable small molecule inhibitor of BK virus replication. Orthogon has secured over $12.50m in investment to date and has additional discovery programs, including a treatment for antibiotic-resistant bacterial infections. The company was founded by Ali Munawar, a veteran biotech entrepreneur, and experienced drug discovery scientists with a mission to prolong and improve patient quality of life. | Pharmaceuticals: Major | Director/Board Member | |
Giiant Pharma, Inc.
Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
BioCurate Pty Ltd. | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 40 |
Israël | 4 |
Verenigd Koninkrijk | 3 |
Griekenland | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 30 |
Finance | 8 |
Consumer Services | 7 |
Communications | 2 |
Technology Services | 2 |
Operationeel
Director/Board Member | 68 |
Corporate Officer/Principal | 49 |
Chief Executive Officer | 29 |
Director of Finance/CFO | 23 |
President | 22 |
Sterkste connecties
Insiders | |
---|---|
Geert Cauwenbergh | 22 |
Martin Schmieg | 20 |
Curtis Lockshin | 20 |
Marie Lindner | 18 |
Robert Bitterman | 12 |
Stephen J. Fanning | 12 |
John Graham | 11 |
Jonathan Freeman | 10 |
Jason Davis | 10 |
Michael E. Macaluso | 10 |
Jason Stein | 9 |
Susan Stranahan Ciallella | 8 |
Kimberly Forbes-McKean | 8 |
Susan Morano | 7 |
John M. Maslowski | 6 |
- Beurs
- Insiders
- Jennifer Phillips
- Bedrijfsconnecties